Labcorp Holdings Inc. (LH): Shareholders' Equity

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$8.62B
As of 2025-12-31
$8.61B
As of 2026-06-30
-5.1%
3-year compound annual growth
-1.8%
5-year compound annual growth
$10.27B2007-12-31: $1.73B2008-12-31: $1.69B2009-12-31: $2.11B2010-12-31: $2.47B2011-12-31: $2.50B2012-12-31: $2.72B2013-12-31: $2.49B2014-12-31: $2.82B2015-12-31: $4.95B2016-12-31: $5.52B2017-12-31: $6.80B2018-12-31: $6.97B2019-12-31: $7.64B2020-12-31: $9.44B2021-12-31: $10.27B2022-12-31: $10.10B2023-12-31: $7.88B2024-12-31: $8.05B2025-12-31: $8.62B$8.62B
2007-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$8.62B+7.0%2026-02-24, Balance as of period end
2024-12-31$8.05B+2.3%2026-02-24, Balance as of period end
2023-12-31$7.88B-22.0%2026-02-24, Balance as of period end
2022-12-31$10.10B-1.7%2025-02-25, Balance as of period end
2021-12-31$10.27B+8.9%2024-02-26, Balance as of period end
2020-12-31$9.44B+23.5%2023-02-28, Balance as of period end
2019-12-31$7.64Bn/c2022-02-25, Balance as of period end
2018-12-31$6.97B+2.5%2021-02-25, Balance as of period end
2017-12-31$6.80B+23.3%2020-02-28, Balance as of period end
2016-12-31$5.52B+11.6%2019-02-28, Balance as of period end
2015-12-31$4.95B+75.3%2018-02-27, Balance as of period end
2014-12-31$2.82B+13.2%2017-02-27, Balance as of period end
2013-12-31$2.49B-8.3%2016-03-01, Balance as of period end
2012-12-31$2.72B+8.5%2015-02-26, Balance as of period end
2011-12-31$2.50B+1.5%2014-02-25, Balance as of period end
2010-12-31$2.47B+17.1%2013-02-26, Balance as of period end
2009-12-31$2.11B+24.7%2012-02-24, Balance as of period end
2008-12-31$1.69B-2.1%2011-03-07, Balance as of period end
2007-12-31$1.73Bn/a2010-02-24, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Labcorp Holdings Inc. (LH)2025-12-31$8.62B+7.0%
Quest Diagnostics Inc (DGX)2025-12-31$7.21B+5.8%
Fortrea Holdings Inc. (FTRE)2025-12-31$563.50M-58.6%
Natera, Inc. (NTRA)2025-12-31$1.71B+43.2%
RadNet, Inc. (RDNT)2025-12-31$1.36B+19.6%
Guardant Health, Inc. (GH)2025-12-31-$99.31Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$577.31Mn/m
Veracyte, Inc. (VCYT)2025-12-31$1.31B+11.4%
CareDx, Inc. (CDNA)2025-12-31$303.10M-19.9%

Compare LH, DGX, FTRE, NTRA side by side · Screen every company in Services-Medical Laboratories ↗